Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Imaging Services

 

FREE BLOG HBI Awards 2018: Value-driven outcomes tool that increases quality and cuts cost

In 2012, University of Utah Health introduced its Value Driven Outcomes (VDO) tool in both inpatient and ambulatory care, which has resulted in increased quality outcomes and more than $2.5m in cost savings. Providers can engage with the VDO tool to compare themselves to their peers and to identify standard care pathways and supplies that lower the cost of care while providing the best possible outcomes. The tool has been applied to sepsis, total joint replacement and laboratory services leading to improvements in outcomes and reductions in costs. The judges were impressed by the sophistication of the Utah offering. .

FREE BLOG HBI Awards 2018: Programme that minimises radiation doses for CT scans

CT scans, particularly in emergency settings, can generate high doses of radiation. Affidea has rolled out a programme across its 235 centres in 16 countries which prescribes levels for 72 different CT scans. This is based on its database of 75,000 examinations a month. This has led to Affidea creating 105 unified protocols to standardize operating procedures for CT scans. This program is key to Affidea’s strategy for winning international tenders.

FREE BLOG HBI Awards 2018: Measuring fat and muscle more accurately with MRI scans

The medical community relies on the notoriously inaccurate Body Mass Index (BMI) measurement when it comes to measuring body fat. AMRA has developed a way of producing 3D-volumetric fat and muscle measurements using a single six-minute MRI scan which is far more accurate. This will enable doctors to better identify at risk patients such as those with high fat levels in the abdomen – visceral fat. Elderly patients with muscle loss and increased fat, a debilitating condition known as sarcopenia, can also be identified. AMRA has introduced a new paradigm where rapid, 6-minute whole body MRI scans are analysed to produce precise, three – dimensional volumetric fat and muscle measurements. This standardized, automated method eliminates reader variability and reduces processing costs. AMRA also researches the relationships between fat, muscle and the development of disease, with the aim to become the new global standard in body composition. AMRA’s aim is also to support the precise tracking of treatment effects, the identification of who should participate in clinical trials, and the understanding of those who are at risk of developing disease.

FREE BLOG HBI Awards 2018: A low-band width teleradiology platform

Teleradiology Solutions, an Indian company which reads images remotely, has produced a platform that works on low-speed bandwidth, making it accessible in areas with poor digital infrastructure, particularly in rural areas of Africa and India. This works on a pay-per-click model making it more affordable and suited to small institutions as well as larger providers. It claims a 99% accuracy rate, 2% higher than the American College of Radiology standard of 97%. With coverage 365 days of the year, 24 hours per day, it is able to turn around emergency image reads in 15 minutes. It currently works in over 20 countries including the United States, Singapore, Nigeria, Tanzania, Uganda, Maldives and India.

FREE BLOG HBI Awards 2018: Using spare capacity to offer low-cost imaging

Virtual network of 38 diagnostic centres in Switzerland, set to increase to 45-50 by June 2018. Corpus has built a platform providing flat rate imaging to HMOs and doctors for a discount of between 10% and 45%. This is achieved by acting as a preferred provider organisation for its partners, and through building volume with local exclusivity offerings for its diagnostic centres, directing patients from HMOs to these centres.

Abraaj sold out of court protection to Colony Capital

Abraaj Holdings and its fund management arm Abraaj Investment Management (AIM) have been sold out of provisional liquidation to Colony Capital, which changed its name from Colony Northstar in June 2018. The deal does not include the troubled Abraaj Global Health Fund, which has been hived off to Alix Partners. Colony is a listed US REIT with global ambitions.

Payor-operator agreement heralds quiet revolution in Czech Republic

A quiet healthcare revolution is taking place in the Czech Republic. For the first time in almost two decades, providers and payors have reached an agreement on fees without the need for intervention by the Ministry of Health. Healthcare Europa speaks to an operator who says this is great news for private providers and a large step towards the creation of a more open market.

Unilabs: Culture and brand transformation

A year ago we spent an evening with Jos Lamers, the CEO of Unilabs. A company doctor, who specialises in turning companies around, Lamers changed 80% of the top 100 top managers at Unilabs within 18 months of arrival. He decidedly (and correctly) delegated responsibility for achieving ambitious targets down to national managers. Yet here was this ambitious, tough-talking CEO enthusiastically describing the value of 360 degree reviews, the need for senior managers to reveal their vulnerabilities and ways in which people can achieve personal and performance change within the workplace. Blending a pragmatic, turnaround mindset with an appreciation of the softer skills required for managing change as clearly worked. Unilabs has dramatically lowered churn, upped organic growth and halved recruitment costs. We talked to Samantha Laurent, Unilabs’ Chief People Officer to find out more.

Mehilainen sold to CVC

Mehilainen, the big Finnish occupational outpatient group has been sold in a deal valued at around €1.8bn to CVC by Triton and KKR. We talk to Mehilainen CEO Janne-Olli Järvenpää about the deal and growth plans. Will he look outside Finland?

Brazilian IPOs show an improving market – but were they a success?

Brazilian Healthcare providers Notre Dame Intermédica and Hapvida have both just gone public. Healthcare Nova speaks to a Brazil-based healthcare expert who shares his thoughts on whether the IPOs were successful, and what this means for the wider Brazilian healthcare market.

Find Us